ArticleActa pharmaceutica Sinica. B2026

Deuterium modification of tyrosine kinase inhibitors contributes to reversing ferroptosis resistance through upregulation of aldehyde oxidase 1 in hepatocellular carcinoma.

Yue Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.